Sigyn Therapeutics SIGY Stock
Sigyn Therapeutics Price Chart
Sigyn Therapeutics SIGY Financial and Trading Overview
| Sigyn Therapeutics stock price | 5.25 USD |
| Previous Close | 0.07 USD |
| Open | 0.09 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.07 - 0.07 USD |
| 52 Week Range | 0.07 - 0.48 USD |
| Volume | 1.41K USD |
| Avg. Volume | 3.42K USD |
| Market Cap | 3.01M USD |
| Beta (5Y Monthly) | -0.978542 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SIGY Valuation Measures
| Enterprise Value | 5.39M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.629 |
Trading Information
Sigyn Therapeutics Stock Price History
| Beta (5Y Monthly) | -0.978542 |
| 52-Week Change | -71.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.48 USD |
| 52 Week Low | 0.07 USD |
| 50-Day Moving Average | 0.12 USD |
| 200-Day Moving Average | 0.19 USD |
SIGY Share Statistics
| Avg. Volume (3 month) | 3.42K USD |
| Avg. Daily Volume (10-Days) | 1.17K USD |
| Shares Outstanding | 42.98M |
| Float | 11.35M |
| Short Ratio | N/A |
| % Held by Insiders | 67.46% |
| % Held by Institutions | 8.72% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:150 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -232.35% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -2048822 USD |
| Net Income Avi to Common (ttm) | -3592807 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 322.33K USD |
| Total Cash Per Share (mrq) | 0.007 USD |
| Total Debt (mrq) | 2.7M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.146 |
| Book Value Per Share (mrq) | -0.055 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1933244 USD |
| Levered Free Cash Flow (ttm) | -579300 USD |
Profile of Sigyn Therapeutics
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 2468 Historic Decatur Road |
| ZIP | 92106 |
| Phone | (619) 353-0800 |
| Website | https://www.sigyntherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Sigyn Therapeutics, Inc. operates as a medical technology company, focuses on creating therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, the cause of hospital deaths. The company also engages in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; CytoVesicles; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. It also developing ChemoPrep to enhance the tumor site delivery of chemotherapy; and ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis. The company is headquartered in San Diego, California.
Q&A For Sigyn Therapeutics Stock
What is a current SIGY stock price?
Sigyn Therapeutics SIGY stock price today per share is 5.25 USD.
How to purchase Sigyn Therapeutics stock?
You can buy SIGY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sigyn Therapeutics?
The stock symbol or ticker of Sigyn Therapeutics is SIGY.
Which industry does the Sigyn Therapeutics company belong to?
The Sigyn Therapeutics industry is Biotechnology.
How many shares does Sigyn Therapeutics have in circulation?
The max supply of Sigyn Therapeutics shares is 1.22M.
What is Sigyn Therapeutics Price to Earnings Ratio (PE Ratio)?
Sigyn Therapeutics PE Ratio is now.
What was Sigyn Therapeutics earnings per share over the trailing 12 months (TTM)?
Sigyn Therapeutics EPS is -3 USD over the trailing 12 months.
Which sector does the Sigyn Therapeutics company belong to?
The Sigyn Therapeutics sector is Healthcare.